Christopher Thompson

Christopher Thompson obtained his PhD in Physical Chemistry at the University of Massachusetts Amherst. He spent 17 years at Bruker Daltonics in various scientific roles, ultimately as Global Business Development Manager for the FT-ICR business unit. Chris moved to BrightSpec in late 2020 to lead the commercialization of MRR, and is currently the Vice President of Commercial Development.